The Capital Group Companies, Inc. reduced its holding of INNOVENT BIO (01801) by approximately 3,327,400 shares at a price of around HK$31.55 per share.

22/01/2025

On January 20th, The Capital Group Companies, Inc. reduced its holdings in Sino Biopharmaceutical (01801) by 3,327,405 shares, priced at 31.5469 Hong Kong dollars per share, for a total amount of approximately 105 million Hong Kong dollars.

According to the latest data from the Hong Kong Stock Exchange, on January 20, The Capital Group Companies, Inc. reduced its holdings of INNOVENT BIO (01801) by 3,327,405 shares, at a price of 31.5469 Hong Kong dollars per share, with a total amount of approximately 105 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 96,778,400 shares, with a shareholding proportion of 5.91%.

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.